Compared to 2D culture, breast cancer (MCF-7 and BT474) models demonstrated increased resistance to doxorubicin, whereas SKBR3 and BT474 breast cancer cells exhibited augmented sensitivity to lapatinib, attributing to elevated phosphorylation levels of epidermal growth factor receptor and protein kinase B. The gene discussed is EGFR; the disease is breast carcinoma.